ArticleIntensive care medicine2026
Persistent tissue hypoperfusion improves risk stratification beyond vasopressor dose in refractory septic shock: a secondary analysis of the ANDROMEDA-SHOCK-2 trial.
Eduardo Kattan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.